Michael Pourdehnad

Michael Pourdehnad

Company: Bristol Myers Squibb

Job title: VP, Early Clinical Development, Hematology/Oncology & Cell Therapy


Seminar: Clinical Activity of Novel Celmod CC-99282 in Patients with Non-Hodgkin Lymphoma

For more information on this session, please download the full event guide.

Day: Day One

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.